CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member:
Volume: 14 Issue: 10
Author(s): Yanqing Gao
Affiliation:
Export Options
About this article
Cite this article as:
Gao Yanqing, Meet Our Editorial Board Member:, CNS & Neurological Disorders - Drug Targets 2015; 14 (10) . https://dx.doi.org/10.2174/187152731410151127124224
DOI https://dx.doi.org/10.2174/187152731410151127124224 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent progress in the development of anthrax vaccines
Recent Patents on Biotechnology Post Traumatic Lesion absence of β-Dystroglycan-Immunopositivity in Brain Vessels Coincides with the Glial Reaction and the Immunoreactivity of Vascular Laminin
Current Neurovascular Research Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Current Drug Targets The Changing Face of Tobacco Use Among United States Youth
Current Drug Abuse Reviews The Pathobiology of Osteoarthritis and the Rationale for Using the Chondroitin Sulfate for its Treatment
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Memantine: Its Role in Vascular Dementia
Drug Design Reviews - Online (Discontinued) Molecular and Biochemical Changes of the Cardiovascular System due to Smoking Exposure
Current Pharmaceutical Design Role of Lipoxins and Resolvins as Anti-Inflammatory and Proresolving Mediators in Colon Cancer
Current Molecular Medicine Oleamide in <i>Ipomoea</i> and <i>Dillenia</i> Species and Inflammatory Activity Investigated through Ion Channel Inhibition
Current Pharmaceutical Biotechnology Advances in Stem Cells Transplantation for the Therapy of Parkinson’s Disease
Current Stem Cell Research & Therapy High Throughput Metabolomics in Clinical Studies: Review and New Applications to Remote Ischemic Preconditioning
Current Topics in Medicinal Chemistry Matrix Metalloproteinase Knockout Studies and the Potential Use of Matrix Metalloproteinase Inhibitors in the Rheumatic Diseases
Current Drug Targets - Inflammation & Allergy Potential Role of Rho Kinase Inhibitors in Combating Diabetes-Related Complications Including Diabetic Neuropathy-A Review
Current Diabetes Reviews Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry
Current Neuropharmacology Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
Current Psychopharmacology Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?
Current Medicinal Chemistry Chemical Aspects of Pharmacological Prophylaxis Against Nerve Agent Poisoning
Current Medicinal Chemistry Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Status Epilepticus: An Overview
Current Drug Metabolism Cyclooxygenase Inhibition in Ischemic Brain Injury
Current Pharmaceutical Design